By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


22nd Century Group, Inc. 

8201 Main Street
Suite 6
Williamsville  New York  14221  U.S.A.
Phone: 716-270-1523 Fax: 716-877-3064




Company News
22nd Century Group, Inc. Receives Guidance From FDA On Phase III Clinical Trials 6/22/2017 12:32:20 PM
22nd Century Group, Inc. Produces Non-GMO Very Low Nicotine Tobacco 6/8/2017 12:55:18 PM
22nd Century Group, Inc. And Dent Neurosciences Research Center To Partner On Brain Imaging Clinical Trial 6/8/2017 8:17:29 AM
22nd Century Group, Inc. Raises 2017 Revenue Projection To $16Million – Another Record Year 5/10/2017 12:09:58 PM
22nd Century Group, Inc. Files 2017 First Quarter Report And Announces Conference Call To Provide Business Update 5/9/2017 6:40:11 AM
FDA Authorizes Clinical Trial For 22nd Century Group, Inc.’s BRAND B Low Tar-to-Nicotine Ratio Cigarettes 5/1/2017 6:16:17 AM
22nd Century Group, Inc. Accepted To Present Proprietary Smoking Cessation Product At BIOCHINA Partnering Forum In Zhuhai, China 4/26/2017 2:06:27 PM
22nd Century Group, Inc. Will Play Leading Role In Industrial Hemp Industry 4/20/2017 9:41:53 AM
World-Renowned Smoking Cessation Scientist, Dr. Michael Cummings, To Present Keynote Address At 22nd Century Group, Inc. Annual Shareholder Meeting 4/18/2017 8:51:52 AM
22nd Century Group, Inc.’s "Non- Or Minimally-Addictive" Cigarettes Gaining Support Of Leading Tobacco Scientists Around The World 3/30/2017 8:47:23 AM